Page last updated: 2024-11-06

mitomycin and Frontotemporal Lobar Degeneration

mitomycin has been researched along with Frontotemporal Lobar Degeneration in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Frontotemporal Lobar Degeneration: Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU PROTEIN inclusions. FTLD includes three clinical syndromes: FRONTOTEMPORAL DEMENTIA, semantic dementia, and PRIMARY PROGRESSIVE NONFLUENT APHASIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ke, YD1
Ke, Y1
Dramiga, J1
Schütz, U1
Kril, JJ1
Ittner, LM1
Schröder, H1
Götz, J1

Other Studies

1 other study available for mitomycin and Frontotemporal Lobar Degeneration

ArticleYear
Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Alzheimer Disease; Amygdala; Animals; Astrocytes; Cell Differentiation; Cell Line, Tumor; Cytoplasm;

2012